If a health issue is unrelated to the trial drug, how is it usually categorized?

• A. SUSAR
• B. Adverse Event
• C. Serious Adverse Event
• D. Unexpected Adverse Event

Answer: (B)

In clinical trials, any health issue that happens to a participant is recorded as an adverse event, and causality to the trial drug is assessed separately. If the issue has no relationship to the drug, it does not meet the criteria for a SUSAR (which requires suspected drug-relatedness) or for being an Unexpected Adverse Event (which depends on whether it’s described in product information). It also isn’t automatically a Serious Adverse Event unless it meets the seriousness criteria (death, life-threatening, hospitalization, etc.). So when the health issue is unrelated to the drug, the usual categorization is an Adverse Event. If it later is judged to be serious, it would be an SAE, but still not a SUSAR because the drug-relatedness is not established.